Literature DB >> 19365957

[Diagnosis of infection Chlamydia trachomatis by PCR among patients in the Specialty Clinic of Women of the National Defense Secretary].

Virginia Sánchez Monroy1, Adolfo Evaristo Torres Mata, José D'Artagnan Villalba Magdaleno.   

Abstract

INTRODUCTION: Infection with Chlamydia trachomatis is a sexually transmitted bacterial disease most common in the world.
MATERIAL AND METHODS: Determination through the PCR technique the presence of C. trachomatis in 98 cervical samples by amplifying a fragment of DNA plasmid cryptic. We investigated medical variables of interest and contraceptive methods in the population. Variables were compared between the positive and negative patients to infection with C. trachomatis using the test of Mann-Whitney U test and Chi square with the program SigmaStat version 2.0. We considered statistically significant as those values of p < 0.001.
RESULTS: 20 samples were found positive for infection with C. trachomatis of the 98 patients studied, indicating a prevalence of 20.4% of the total group. The variables analyzed showed a statistically significant difference in the number of abortions, which were higher for patients positive for the infection.
CONCLUSIONS: The prevalence found in this study suggests that infection with C. trachomatis is an issue of concern in public health, it requires the count on diagnostic techniques, such as PCR favoring an increase in the detection and early treatment in reducing the spread of the infection and long-term sequelae, so that justifies his provide detection in a broader way.

Entities:  

Mesh:

Year:  2009        PMID: 19365957

Source DB:  PubMed          Journal:  Ginecol Obstet Mex        ISSN: 0300-9041


  1 in total

1.  [Prevalence and phylogenetic analysis of Chlamydia trachomatis in a population of women in Posadas, Misiones].

Authors:  G B Jordá; S E Hanke; J M Ramos-Rincón; J Mosmann; M L Lopéz; A C Entrocassi; C Cuffini
Journal:  Rev Esp Quimioter       Date:  2017-02-16       Impact factor: 1.553

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.